TRANSCENTA-B: VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON PROMISING ANTI-TUMOR ACTIVITYOF NOVEL FGFR2B TARGETING ADC WITH SITE-SPECIFICCONJUGATED TOPO I INHIBITOR PAYLOAD IN PRECLINICAL TUMOR MODELS AT AACR 2025

Apr 29 18:01 ET

TRANSCENTA-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS

Apr 22 04:40 ET

TRANSCENTA-B: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS

Apr 22 04:39 ET

TRANSCENTA-B: 2024 Environmental, Social and Governance Report

Apr 22 04:38 ET

TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025

Apr 7 07:08 ET

TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025

Mar 6 03:37 ET

TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025

Feb 6 03:37 ET

TRANSCENTA-B: Next Day Disclosure Returns

Jan 14 06:06 ET

TRANSCENTA-B: Next Day Disclosure Returns

Jan 10 06:22 ET

TRANSCENTA-B: Change of Address of Principal Place of Business in Hong Kong

Jan 10 03:30 ET

TRANSCENTA-B: Next Day Disclosure Returns

Jan 9 05:45 ET

TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

Jan 7 03:48 ET

TRANSCENTA-B: Next Day Disclosure Returns

Jan 3 05:31 ET

TRANSCENTA-B: Next Day Disclosure Returns

Dec 31, 2024 02:51 ET

TRANSCENTA-B: VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON PROMISING ANTI-TUMOR ACTIVITY OF NOVEL LIV-1 TARGETING ADCS WITH SITE-SPECIFIC CONJUGATED TOPO I INHIBITOR PAYLOAD IN TNBC TUMOR MODELS AT 2024 SABCS

Dec 12, 2024 17:07 ET

TRANSCENTA-B: Next Day Disclosure Returns

Dec 5, 2024 06:33 ET

TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Dec 5, 2024 05:01 ET

TRANSCENTA-B: Next Day Disclosure Returns

Nov 27, 2024 06:01 ET

TRANSCENTA-B: Next Day Disclosure Returns

Nov 21, 2024 06:34 ET

TRANSCENTA-B: Next Day Disclosure Returns

Nov 20, 2024 05:50 ET